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INTRODUCTION 
An antioxidant may be defined as a substance 
that when present at low concentrations , 
compared with those of the oxidizable substrate, 
significantly delays or inhibits its oxidation [1 J. 
Nowadays there are several commercial dietary 
supplements which claim for antioxidant activity. 
In this work , the antioxidant activity (AA) of 17 
dietary supplements (Table 1) available in 
different formulations (pills, capsules or bags) , 
was evaluated by in vitro assays: scavenging 
activity of 2,2-d iphenyl-1 -picrylhydrazyl (OPPH) 
radicals , reducing power (RP) and inhibition of 
lipid peroxidation by preventing the formation of 
th iobarbituric acid reactive substances (TBARS). 
Furthermore, different combinations (8+10+17, 
8+ 10, 8+17 and 10+17) of some samples were 
also tested in order to obtain potential synergistic 
effects. 
Linear discriminant analysis (LDA) was used to 
categorize the condensed formulations (pills and 
capsules), the infusion bags and the combined 
samples, according with their antioxidant activity. 
The Advanced Antioxidant Formula (AAF; 
sample 8) proved to have the highest antioxidant 
activity in all the assayed methods, either singly 
taken or included in mixtures. Furthermore, the 
mixtures containing this supplement revealed 
synergistic effects in 92% of the cases. The 
intake of antioxidant mixtures might provide 
some additional benefits. 
MATERIAL AND METHODS 
The samples were prepared using the available 
formulation (Table 1). Each sample was 
weighted and prepared in 200 mL of distilled 
water in order to obtain a stock-solution. Pills 
and the inner part of the capsules were 
dissolVed, while bags were used after infusion. 
Several dilutions of each stock-solution were 
prepared to perform the antioxidant activity 
assays. 
The antioxidant activity of the individual and 
combined samples was evaluated by DPPH 
radical -scavenging activity , reducing power and 
inhibition of lipid peroxidation in brain 
homogenates, using TBARS assay. The extract 
concentrations providing 50% of antioxidant 
activity or 0.5 of absorbance (EGso) were 
calculated from the graphs of antioxidant activity 
percentages (OPPH and TBARS assays) or 
absorbance at 690 nm (RP assay) against 
extract concentrations. Trolox was used as 
standard [2J . 
All the assays were carried out in triplicate in 
three different samples of each supplement. The 
results are expressed as mean value±standard 
deviation (SO). One-way analysis of variance 
(ANOVA) was applied following Tukey's honestly 
significant difference post hoc test with a ~ 0.05 , 
coupled with Welch's statistic. The 
homoscedasticity of distribution was checked 
through Levene's test. 
In addition, LOA was used as a supervised 
learning technique to classify the assayed 
antioxidant dietary supplements according to 
their antioxidant activity results. A stepwise 
technique, using the Wilks' A method with the 
usual probabilities of F, was applied for variable 
selection, verifying which canonical discriminant 
functions were significant. To avoid 
overoptimistic data modulation , a leaving-one-
out cross-validation procedure was carried out to 
assess the model performance. 
RESULTS AND DISCUSSION 
The AAF (sample 8) proved to have the highest 
antioxidant activity in all the assayed methods 
(Figure 1), providing the best results (lowest 
ECso values), either singly taken or included in 
mixtures. 
Table 1 -Identification of the dietary supplements and 
concentrations of the prepared stock-solutions. 
Formulatloll Slock· Commercial designation solution 
(mgimL) 
(1 ) Selenium ACE Pill 1.98 
(2) Selenium Good' N Natural Pi ll 3.07 
(3) VilaSerry ACE Pil l 2.89 
(4) Biaactiv~ Antiaxidanl PharmaNard Pill 5.29 
(5) Anti-aging firming Pil l 3.68 
(6) Kyalic aged garl ic Capsule 2.16 
(7) Form + Capsule 1.87 
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(10) Resveralrol 
(1 1) Green coHee Arkocapsules 
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(16) Horsetail infusion 
(17) Colesterol control 
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Figure 1 - Antioxidant activity, expressed as ECso 
values (mg/mL), of the studied dietary supplements . 
Furthermore, for DPPH radical scavenging 
activity, as well as for reducing power assays, 
the selected mixtures were always synergistic 
(increase of antioxidant capacity). The synergist 
effect predominated also in the TSARS inhibition 
assay, being observed in 75% of the mixtures; 
8+ 10 demonstrated an additive effect (Tabte 2). 
Regarding LOA, the assayed dietary antioxidant 
supplements proved to have distinctive features, 
derived from being condensed or infusion 
formulas. 
Table 2 - Theoreflcal' (Theor.) versus experimental (Exp.) 
values of antiOlodant activity ECso (mg/mL) of the 
combined samples of dietary supplements. 
DPPH RP TSARS 
MIxtures 
Thear. Exp. Thear. Exp. Theor. Exp. 
8 ... 10+17 O.78±O.04 O.14±O.D2 0.18:10.03 0.0710.01 0.4510.01 0.07±O.01 
8+10 O.81±D.D5 O.07±O.01 0.04:10.01 0.Q4±O.01 O.36±O.Ol O.06±O.Ol 
8+17 O.39iO.Ol D.09±O.Ol 025±O.04 O.06±O.Ol O.34iO.Ot O.07iO.Ot 
10+17 1.1S±O.05 O.B4±O.Ol O.26iD.04 O.09±O.Ot O.66±D.Ol O.31±O.Oi 
The effect was considered synergistic when the ECso 
experimental values were more than 5% lower than 
theoretical values. 
Regarding LDA, the assayed dietary antioxidant 
supplements proved to have distinctive features , 
derived from being condensed or infusion 
formulas . Furthermore, it is relatively clear that 
the tested combinations retain an antioxidant 
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profile highly similar to the presented by the 
condensed formulas (pills or capsules) included 
in those mixtures (Figure 2) . 
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Figure 2 - Discriminant functions coefficients defined 
according with the antioxidant activity ECso values of 
the dietary supplements. 
CONCLUSIONS 
AAF revealed to be the most active supplement. 
In addition, the mixtures containing this 
supplement revealed synergistic effects in 92% 
of the cases. 
The antioxidant activity of these mixtures was 
closely related wi th that presented by the 
condensed formulations when assayed 
individually . Thereby, the same beneficial effects 
might be achieved ingesting lower quantities of 
the condensed supplements. 
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